Merit Medical Is Maintained at Outperform by Barrington Research
Merit Medical Systems Analyst Ratings
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $114
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI) and Thermo Fisher (TMO)
Outperform Rating for Merit Medical Systems Bolstered by Positive WAVE Trial Results and Strategic Acquisitions
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $125
Wells Fargo Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $109
A Quick Look at Today's Ratings for Merit Medical Systems(MMSI.US), With a Forecast Between $103 to $110
Key Takeaways From Merit Medical Systems Analyst Ratings
A Quick Look at Today's Ratings for Merit Medical Systems(MMSI.US), With a Forecast Between $103 to $125
Merit Medical Is Maintained at Neutral by B of A Securities
Hold Rating on Merit Medical Systems Amid Wrapsody's Positive Impact and Market Uncertainties
Merit Medical Systems Analyst Ratings
Piper Sandler Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $110
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $105
Merit Medical Systems Analyst Ratings
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Raises Target Price to $92
Merit Medical Systems: Hold Rating Maintained Amid Balanced Prospects and Premium Valuation